’Nesiritide’ gives the non-medical public an unprecedented insight into the complexity, risk, and competitiveness of drug development,” Mills said. “It demonstrates the devastating impact of media attention to questions of drug safety.
DEXTER, Mich. (PRWEB) September 26, 2016
When Roger M. Mills, M.D., had the chance to make a late-career change from academic cardiology to the pharmaceutical industry, he had no idea what kind of adventures the next decade would bring.
In his new book “Nesiritide: The Rise and Fall of Scios,” Mills gives readers an inside look at the development, early success and subsequent demise of a biotechnology drug that he was personally involved in developing, testing and marketing.
“’Nesiritide’ gives the non-medical public an unprecedented insight into the complexity, risk, and competitiveness of drug development,” Mills said. “It demonstrates the devastating impact of media attention to questions of drug safety.”
After his time at Scios Inc., the company that developed Nesiritide and after retiring from Janssen Research & Development, LLC as a senior director in clinical research, Mills has adopted the mission of better informing the medical community and the general public about the workings of the often-mysterious pharmaceutical industry.
For more information, visit http://www.rmillsmd.com/.
Nesiritide: The Rise and Fall of Scios
By Roger M. Mills, M.D.
Available in softcover, hardcover, e-book
Available on Amazon, Barnes & Noble and iUniverse
About the author
Roger M. Mills, M.D. is a graduate of Amherst College and the University of Pennsylvania medical school. After completing his medical residency, he served in the U.S. Navy before beginning a thirty-year career in academic clinical cardiology as a research fellow at Harvard’s Peter Bent Brigham hospital. He joined Scios Inc., a Johnson & Johnson operating company, in 2005 and later moved to J&J's Janssen Research and Development, LLC. He retired after a 10-year career with J&J, and now lives in Dexter, Mich. with his wife, Katherine, and their Labrador retriever, Posie.
# # #
For review copies or interview requests, contact: